NCT07204262Completed
Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma
Integrating Longitudinal Biomarker Dynamics With Clinical Features for Prognostic Prediction in Hepatocellular Carcinoma
Source: ClinicalTrials.gov · Last updated 2 Oct 2025
Brief summary (registry, in English)
To evaluate whether tracking changes in key blood markers over time, together with clinical features, can improve the prediction of outcomes in patients with hepatocellular carcinoma (HCC). By developing a trajectory-based prognostic model, we aim to provide more accurate risk assessment and support personalized treatment decisions.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 379 (actual)
- First submitted
- 24 Sept 2025
- Start date
- 1 Jan 2018
- Primary completion date
- 1 Nov 2024
- Lead sponsor
- Xu Yong, MD
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT07204262
What you commit to
- Study type: Observational
- Participants enrolled: 379
- From 1 Jan 2018 to the primary completion date, 1 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Non-primary liver cancer;
Other
- baseline data missed;
- incomplete follow-up data;
- Unevaluable lesions.
Who the study is looking for
- pathologically or radiologically confirmed HCC;
- availability of pre- treatment clinical record, radiological and hematological data and more than 2 cycles of post-treatment data;
- receipt of treatment during the study period;
- Age rather than 18 years old.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shenzhen Third People's Hospital Coordinator of this site? Confirm its status | Shenzhen | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.